ArticlePloS one2017

A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

Christopher J Lynch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.